Welcome to our dedicated page for Nano Labs SEC filings (Ticker: NA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Finding precise R&D costs for Nano Labs鈥� Flow Processing Unit or untangling its cryptocurrency asset footnotes can feel like searching for a single transistor on a wafer. Nano Labs insider trading Form 4 transactions, segment disclosures on high throughput computing chips, and risk factors tied to Chinese supply chains all sit inside hundreds of pages of technical prose. Investors often ask, 鈥淲here can I find Nano Labs quarterly earnings report 10-Q filing?鈥� or 鈥淗ow is blockchain exposure reported in the 10-K?鈥濃�攖he answers are buried deep in EDGAR.
Stock Titan solves that complexity with AI-powered summaries that translate every line item into clear language. Whether you need Nano Labs Form 4 insider transactions real-time, Nano Labs proxy statement executive compensation details, or Nano Labs 8-K material events explained, our engine delivers instant context. Interactive tools highlight which paragraphs discuss FPU architecture capex, while side-by-side views compare gross-margin trends across filings. You鈥檒l also receive real-time alerts the moment a Nano Labs executive stock transactions Form 4 hits the system, so you never miss a trade.
Use our platform to:
- Review Nano Labs annual report 10-K simplified鈥攑inpoint crypto asset valuations without parsing accounting jargon.
- Dive into Nano Labs earnings report filing analysis to track near-memory HTC chip revenue quarter-over-quarter.
- Accelerate due diligence by understanding Nano Labs SEC documents with AI before markets react.
Nano Labs Ltd (NASDAQ: NA) filed Prospectus Supplement No. 4 to its May 2 2025 F-1 prospectus to register the potential resale of 652,174 Class A ordinary shares that may be issued upon exercise of outstanding warrants. The supplement incorporates three Form 6-K reports dated 2, 7 and 8 July 2025 and attaches the full warrant agreement, placement documents and Cayman legal opinions.
Key terms
- The warrants were issued in an April 11 2024 private placement and carry an $10.00 exercise price, initial exercise date of June 2025 and five-year term.
- The closing share price on 8 July 2025 was $7.86, below the exercise price, making near-term cash exercise unlikely.
- Exercise may be for cash or, under certain conditions, via cashless exercise. Anti-dilution provisions adjust the exercise price for stock splits, dividends, or dilutive issuances.
- No primary shares are being sold by the company; the selling shareholders will bear selling commissions. Nano Labs would receive proceeds only if warrants are exercised.
- The supplement reiterates high-risk disclosures and incorporates Cayman counsel鈥檚 opinion that the shares, when issued, will be validly issued, fully paid and non-assessable.
Investor implications
- Dilution potential: Full exercise would add ~2.3 % to current Class A float (based on ~28 m shares outstanding in last 20-F).
- Limited immediate impact: With the warrants currently out-of-the-money, cash inflow to Nano Labs is uncertain and resale volume depends on future share price performance.
- Legal clarity: Filing provides detailed warrant mechanics, tax opinions and confirms incorporation of recent 6-K disclosures into the registration statement.
FAQ
What is the current stock price of Nano Labs (NA)?
What is the market cap of Nano Labs (NA)?
